BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20307927)

  • 1. Genetic heterogeneity of inflammatory response and skin tumorigenesis in phenotypically selected mouse lines.
    Galvan A; Vorraro F; Cabrera WH; Ribeiro OG; Pazzaglia S; Mancuso M; Zolin A; Milani S; Saran A; Ibañez OM; Dragani TA
    Cancer Lett; 2010 Sep; 295(1):54-8. PubMed ID: 20307927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of genetic modification of acute inflammatory responsiveness on tumorigenesis in the mouse.
    Biozzi G; Ribeiro OG; Saran A; Araujo ML; Maria DA; De Franco M; Cabrera WK; Sant'anna OA; Massa S; Covelli V; Mouton D; Neveu T; Siqueira M; Ibanez OM
    Carcinogenesis; 1998 Feb; 19(2):337-46. PubMed ID: 9498286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of chemical carcinogenesis: analysis of bidirectional selective breeding inducing maximal resistance or maximal susceptibility to 2-stage skin tumorigenesis in the mouse.
    Saran A; Neveu T; Covelli V; Mouton D; Pazzaglia S; Rebessi S; Doria G; Biozzi G
    Int J Cancer; 2000 Nov; 88(3):424-31. PubMed ID: 11054672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse genetic predisposition to colon versus lung carcinogenesis in mouse lines selected based on acute inflammatory responsiveness.
    Di Pace RF; Massa S; Ribeiro OG; Cabrera WH; De Franco M; Starobinas N; Seman M; Ibañez OC
    Carcinogenesis; 2006 Aug; 27(8):1517-25. PubMed ID: 16774945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses.
    Meeran SM; Vaid M; Punathil T; Katiyar SK
    Carcinogenesis; 2009 Mar; 30(3):520-8. PubMed ID: 19158151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intercross outbred mice and single nucleotide polymorphisms to map skin cancer modifier loci.
    Peissel B; Zaffaroni D; Pazzaglia S; Manenti G; Zanesi N; Zedda I; Rebessi S; Covelli V; Dragani TA; Saran A
    Mamm Genome; 2001 Apr; 12(4):291-4. PubMed ID: 11309660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 7,12-dimethylbenz(a)anthracene-DNA adduction in the epidermis of two lines of mice selected for resistance (CAR-R) or susceptibility (CAR-S) to skin carcinogenesis.
    Perin F; Perin O; Barat N; Plessis MJ; Saran A; Pioli C; Covelli V; Biozzi G; Mouton D
    Cancer Res; 1994 Sep; 54(17):4635-40. PubMed ID: 8062256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic susceptibility to tumor progression in mouse skin carcinogenesis.
    Stern MC; Conti CJ
    Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of both skin and lung tumorigenesis by Car-R mouse-derived cancer modifier loci.
    Saran A; Zaffaroni D; Pazzaglia S; Peissel B; Galbiati F; Spinola M; Manenti G; Zanesi N; Rebessi S; Mancuso MT; Covelli V; Dragani TA
    Int J Cancer; 2002 Feb; 97(5):580-3. PubMed ID: 11807781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl hydrocarbon receptor polymorphism modulates DMBA-induced inflammation and carcinogenesis in phenotypically selected mice.
    De Souza VR; Cabrera WK; Galvan A; Ribeiro OG; De Franco M; Vorraro F; Starobinas N; Massa S; Dragani TA; Ibañez OM
    Int J Cancer; 2009 Mar; 124(6):1478-82. PubMed ID: 19065662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
    Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
    Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
    Guo Y; Cleveland JL; O'Brien TG
    Cancer Res; 2005 Feb; 65(4):1146-9. PubMed ID: 15734996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of tumor promoting activity of capsaicin, a principal pungent ingredient of red pepper, in mouse skin carcinogenesis.
    Park KK; Chun KS; Yook JI; Surh YJ
    Anticancer Res; 1998; 18(6A):4201-5. PubMed ID: 9891468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of chemical carcinogenesis--II. Papilloma induction and malignant conversion in susceptible (Car-s) and resistant (Car-R) lines of mice produced by bidirectional selective breeding and in their (Car-S X Car-R) F1 hybrids.
    Pioli C; Saran A; Mouton D; Troiani C; Doria G; Covelli V; Neveu T; Biozzi G
    Carcinogenesis; 1994 Nov; 15(11):2629-35. PubMed ID: 7955117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
    Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
    Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.
    Tiano HF; Loftin CD; Akunda J; Lee CA; Spalding J; Sessoms A; Dunson DB; Rogan EG; Morham SG; Smart RC; Langenbach R
    Cancer Res; 2002 Jun; 62(12):3395-401. PubMed ID: 12067981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.